2. Lysosomal storage disease caused by an autosomal
recessive mutation in the β glucocerebrosidase gene
(also called glucosylceramidase and β glucosidase)
Defective enzyme leads to accumulation of
glucocerebroside substrate in cells of the mononuclear
phagocyte system, including histiocytes in the spleen,
lymph nodes, bone marrow, GI and GU tracts; Kupffer
cells in liver; osteoclasts in bone; microglia in CNS; and
alveolar macrophages in lungs
4. All types
Hepatosplenomegaly
Bone: bone crises , osteoporosis, avascular necrosis of the femur
Blood abnormalities: anemia, thrombocytopenia, pancytopenia
Pulmonary manifestations
Growth delays
Type II
Congenital ichthyosis (collodion baby), acute neurodegeneration
Death within the first years of life [3]
Type III
Gradual onset of symptoms
Neurodegeneration
11. Diagnostics
with
histological
findings…
Reduced glucocerebrosidase activity in leukocytes or fibroblasts
Accumulation of glucocerebroside in leukocytes or fibroblasts
Gaucher cell: lipid-rich macrophages with an enlarged cytoplasm with
inclusions that resemble crumpled tissue paper on microscopy
Microscopic (histologic) description
Enlarged Kupffer cells and portal macrophages with “crinkled paper”
cytoplasm
12. Enzyme replacement therapy with imiglucerase
(Cerezyme), a recombinant version of β
glucocerebrosidase, for patients with types I or
III
Surgery – Partial or total splenectomy
Bone marrow transplant
Gene replacement